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DNA methylation and miRNA-1296 act in
concert to mediate spatiotemporal
expression of KPNA7 during bovine oocyte
and early embryonic development
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Abstract
Background: Epigenetic regulation of oocyte-specific maternal factors is essential for oocyte and early embryonic
development. KPNA7 is an oocyte-specific maternal factor, which controls transportation of nuclear proteins
important for early embryonic development. To elucidate the epigenetic mechanisms involved in the controlled
expression of KPNA7, both DNA methylation associated transcriptional silencing and microRNA (miRNA)-mediated
mRNA degradation of KPNA7 were examined.
Results: Comparison of DNA methylation profiles at the proximal promoter of KPNA7 gene between oocyte and 6
different somatic tissues identified 3 oocyte-specific differentially methylated CpG sites. Expression of KPNA7 mRNA
was reintroduced in bovine kidney-derived CCL2 cells after treatment with the methylation inhibitor, 5-aza-2′-
deoxycytidine (5-Aza-CdR). Analysis of the promoter region of KPNA7 gene in CCL2 cells treated with 5-Aza-CdR
showed a lighter methylation rate in all the CpG sites. Bioinformatic analysis predicted 4 miRNA-1296 binding sites
in the coding region of KPNA7 mRNA. Ectopic co-expression of miRNA-1296 and KPNA7 in HEK293 cells led to
reduced expression of KPNA7 protein. Quantitative real time PCR (RT-qPCR) analysis revealed that miRNA-1296 is
expressed in oocytes and early stage embryos, and the expression reaches a peak level in 8-cell stage embryos,
coincident with the time of embryonic genome activation and the start of declining of KPNA7 expression.
Conclusions: These results suggest that DNA methylation may account for oocyte-specific expression of KPNA7,
and miRNA-1296 targeting the coding region of KPNA7 is a potential mechanism for KPNA7 transcript degradation
during the maternal-to-zygotic transition.
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Background
Successful germ cell development and differentiation
during oogenesis and early embryogenesis is accom-
plished through the help of nuclear proteins such as
transcription factors and chromatin-remodeling factors
that act in the nucleus [1]. A family of nuclear trans-
porters called karyopherins are the major players in the
translocation of nuclear proteins through an active,
energy-dependent nuclear import system. To date, seven
members of karyopherin alpha (KPNA) have been
identified in mammals; only KPNA7 is strictly expressed
in oocytes and early embryos [2–4]. In mice, KPNA7
knockout lead to fetal lethality, sex imbalance and
abnormalities of epigenetic modifications (e.g. down-
regulation of histone H3K27me3) [3]. In livestock
species, such as cattle and pigs, knockdown of KPNA7
significantly reduces blastocyst rate through inducing
arrested embryonic development [2, 4]. In cattle, the
expression of KPNA7 is high in germinal vesicle (GV)
oocytes through 8-cell stage embryos but drops to barely
detectable levels in morula and blastocyst stage embryos
[2]. The sudden drop of mRNA levels during the 8–16
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cell stages is coincident with the time of maternal-to-
zygotic transition (MZT) in cattle. To date, little is
known about the mechanistic control of tissue- and
stage-specific expression of KPNA7.
DNA methylation at the 5-position of cytosine (5mC)
largely occurs at CpG dinucleotides and is required for
normal gametogenesis and embryogenesis in mammals
[5]. In the early stages of oogenesis, the genome of
embryonic germ cells is dynamically reprogrammed dur-
ing cell differentiation and the differentially methylated
regions begin to maintain the monoallelic expression of
imprinted genes [6–8]. Genes of developmental import-
ance, such as germ cell-specific factors Nanog, Dazl,
Pou5f1 and Sry, which control primordial germ cell
development, are all regulated through DNA
methylation-mediated mechanisms [9–11]. Tissue-
specific and differentially methylated regions are com-
mon in the mammalian genome and correspond to dif-
ferent cell types in an organism [12]. Since DNA
methylation profile is tissue-specific, it is reasonable to
believe that DNA methylation, particularly, methylation
in the CpG sites located in the proximal promoter sur-
rounding the transcription start site (TSS), plays a role
in controlling the expression of oocyte-specific maternal
factors.
Maternal effect genes are the major driving force to
facilitate oocyte maturation, fertilization and embryonic
genome activation [13]. However, after MZT, almost
90% of the maternal transcripts are degraded and the
clearance of maternal transcripts is proved to be essen-
tial for normal embryonic development [14]. For
example, in Xenopus laevis, abundance of the oocyte-
specific maternal transcript c-mos is reduced quickly
after fertilization, and introducing c-mos protein into 2-
cell stage embryo led to development block [15]. This
phenomenon was observed in the mouse and other
species, which indicates that maternal transcript degrad-
ation is required for normal embryonic development
[16]. Multiple negative regulatory mechanisms including
mRNA deadenylation, interaction with RNA-binding
proteins and miRNA-mediated degradation are involved
in post-transcriptional degradation of maternal tran-
scripts [17]. miRNAs such as miRNA-430 in zebrafish
and miRNA-427 in Xenopus were shown to be present
prior to embryonic genome activation and further
studies revealed more evidence to support the role of
these miRNAs in degradation of hundreds of maternal
transcripts [18–20]. In cattle, a number of oocyte-
specific maternal transcripts (e.g. NPM2, NOBOX and
FIGLA) were shown to be targeted by miRNAs for their
degradation [21–23].
In the present study, we identified oocyte-specific dif-
ferentially methylated CpG sites in the promoter region
of bovine KPNA7 gene and demonstrated that KPNA7
mRNA is potentially targeted by miRNA-1296 for deg-
radation. The results suggest distinctive controlling
mechanisms for tissue- and stage-specific expression of
bovine KPNA7 gene during oocyte and early embryonic
development.
Results
KPNA7 promoter is differentially methylated in bovine
oocyte and somatic tissues
It has been generally believed that DNA hypermethyla-
tion at the proximal promoter can repress gene tran-
scription by interfering with transcription initiation
[24]. Therefore, differentially methylated promoter
region of KPNA7 gene may contribute to its oocyte-
specific expression. Analysis of the genomic DNA
sequence around the transcription start site (TSS) of
KPNA7 gene using an online algorithm (Methprimer)
revealed multiple CpG sites including a CpG island
containing 8 CpG sites (− 221 to − 114) located up-
stream of the TSS (Additional file 1. Figure S1). Using
bisulfite conversion and subsequent DNA sequencing,
the methylation status of 11 consecutive CpG sites
including 8 within the CpG island and 3 located right
before the TSS at the CpG island shore region were
characterized. Three hypomethylated CpG sites (− 149,
− 63 and − 54) with high demethylation rates (60–70%)
were identified in the GV oocyte in comparison to 6
different somatic tissues including heart, lung, muscle,
brain, intestine and spleen (Fig. 1). The hypomethyla-
tion pattern observed in the 3 sites was found to exist
only in the GV oocyte with no more than 20% demeth-
ylation observed in any of the somatic tissues examined,
which indicates a tissue-specific methylation pattern of
these 3 CpG sites.
Treatment with 5-Aza-CdR reintroduces expression of
KPNA7 in CCL-22 cells
CCL-22 cells are derived from bovine kidney cells, which
do not express KPNA7 naturally. 5-Aza-CdR inhibits
activity of DNA methyltransferase 1 (DNMT1), an en-
zyme that maintains the status of DNA methylation. As
cells divide, treatment of 5-Aza-CdR results in global
demethylation of the cell genome, and thereby induces
the expression of genes silenced by DNA methylation
[25]. As shown in Fig. 2a, KPNA7 expression was
induced in the 5-Aza-CdR treated cells. Bisulfite sequen-
cing of CCL-22 cells from the treatment (0.5 μM) and
the control groups showed demethylation of the KPNA7
proximal promoter in the treatment group, whereas in
the control group, hypermethylation was observed
(Fig. 2b), which agrees with the RT-PCR results showing
no expression of KPNA7 mRNA in the control group.
Three oocyte-specific hypomethylated sites (− 149, − 63,
and − 54) are all methylated in the control group, and in
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Fig. 1 Methylation status of 11 CpG sites in the proximal promoter of bovine KPNA7 gene in GV oocytes and 6 somatic tissues. Three tissue-specific
differentially methylated sites (− 149, − 63 and− 54) were detected. Close circles indicate methylated sites; open circles indicate demethylated sites
Fig. 2 5-Aza-CdR treatment of CCL-22 cells reintroduces KPNA7 expression by demethylation of CpG sites in the proximal promoter of bovine
KPNA7 gene. a Expression of KPNA7 was detected in 5-Aza-CdR treated CCL-22 cells by RT-PCR. b Methylation status of 11 CpG sites in the
proximal promoter of bovine KPNA7 gene in the 5-Aza-CdR treated and control CCL-22 cells. Demethylation of the CpG sites in the treatment
group, and hypermethylation of the CpG sites in the control group were observed. Three oocyte-specific hypomethylated sites (− 149, − 63 and
− 54) are all methylated in the control group. Close circles indicate methylated sites; open circles indicate demethylated sites
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the treatment group they underwent partial demethylation
showing resemblance to the methylation status found in
oocytes. These results indicate that DNA methylation in
the proximal promoter of KPNA7 gene is critical for its
tissue-specific expression, and the 3 oocyte-specific hypo-
methylated sites may play a primary role in controlling
KPNA7 tissue-specificity.
Promoter demethylation does not activate KPNA7
expression after embryonic genome activation
As a maternal effect gene, KPNA7 is only expressed in
oocyte and early embryos in which the expression level
is high until it rapidly decreases after MZT (~ 16-cell
stage) and does not increase again until the formation of
primordial germ cells in late pregnancy [2]. Therefore,
16-cell and blastocyst stage embryos were used to test if
silencing of KPNA7 expression was due to DNA methy-
lation in the promoter region. Bisulfite sequencing and
subsequent analysis showed that in 16-cell stage em-
bryos, the KPNA7 proximal promoter is heavily hypo-
methylated (Fig. 3). At the further developmental stage,
when the embryonic genome is completely activated, the
KPNA7 proximal promoter is still extremely hypomethy-
lated. This pattern shows that DNA methylation of the
CpG sites at the proximal promoter does not control
KPNA7 expression in embryos after MZT, and thus
silencing of KPNA7 expression in embryos after the 16-
cell stage is likely due to other mechanisms.
miRNA-1296 is potentially involved in translational
silencing of bovine KPNA7
To identify miRNAs that may target KPNA7, the KPNA7
cDNA sequence (GenBank accession No. FJ754641) was
uploaded to the online algorithm “Microinspector”
(http://bioinfo.uni-plovdiv.bg/microinspector/) to predict
miRNA binding sites. Four miRNA-1296 recognition
elements in the coding region of KPNA7 mRNA were
predicted (Fig. 4). Co-transfection of expression con-
structs harboring miRNA-1296 and KPNA7 showed a
reduction of KPNA7 protein expression in HEK293 cells
compared to the cells transfected with KPNA7 expres-
sion construct alone (Fig. 5a). This experiment was
repeated three times and quantitative analysis of western
blot data showed a significant reduction of KPNA7
protein in the co-transfection group (Fig. 5b). The re-
sults suggest that miRNA-1296 may play a role in the
regulation of bovine KPNA7 expression at the post-
transcriptional level. RT-qPCR analysis showed that
miRNA-1296 expression reaches its peak level in the
8-cell stage embryo, which is coincident with the start of
declining of KPNA7 expression (Fig. 6). The data
supports our hypothesis that miRNA-1296 acts as a
functional physiological regulator for KPNA7 expression
during early embryogenesis.
Discussion
Tissue-specific deferential methylation has become an
important aspect in epigenetic-related gene expression
studies [26, 27]. Comparisons between oocyte and
sperm, developmental germ cell stages, and different
embryonic stages showed stage- or germ cell- specific
differentially methylated regions [28, 29]. In this study,
we demonstrated that methylation of 3 CpG sites (− 149,
− 63 and − 54) in the promoter region controls tissue-
specific expression of bovine KPNA7 gene. Two of the
differentially methylated sites are located in the CpG
island shore region (− 63 and − 54). The role of CpG
island shore regions in controlling gene expression has
been recently demonstrated [30, 31].
Control of gene expression by specific CpG sites was
observed in a previous study in prostate cancer cells
[32]. When treated with a minimal concentration of 5-
Fig. 3 Methylation status of 11 CpG sites in the proximal promoter of bovine KPNA7 gene in 16-cell and blastocyst stage embryos. Hypomethylation
of the CpG sites were observed in both stage embryos. Close circles indicate methylated sites; open circles indicate demethylated sites
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Aza-CdR, one CpG site was hypersensitive to the chal-
lenge and methylation of this single site led to silencing
of PMP24 gene. In the present study, we observed that
demethylation of CpG sites tends to spread from the
TSS towards the upstream positions. Two sites (− 63
and − 54) closest to the TSS had the highest demethyla-
tion level than did the sites located upstream, suggesting
a primary role of these 2 sites in controlling the expres-
sion of KPNA7 gene.
After fertilization, the paternal genome undergoes
spontaneous global demethylation before first cleavage
but the maternal genome retains its methylation status
until the first cleavage event in which demethylation
occurs passively with each cell division [33]. In cattle,
Fig. 4 Prediction of miRNA-1296 binding sites in the coding region of bovine KPNA7 mRNA. Four putative miRNA-1296 binding sites (A, B, C and
D) were predicted using the online software Microinspector (http://bioinfo.uni-plovdiv.bg/microinspector/)
Fig. 5 miRNA-1296 suppresses the expression of KPNA7 protein in HEK293 cells. a A representative western blot showing reduction of KPNA7
protein in HEK293 cells expressing miRNA-1296. ACTB was used as a loading control. The experiment was repeated three times. b ImageJ
software was used to quantify the protein bands. Abundance of KPNA7 protein was normalized relative to abundance of ACTB protein. Data are
expressed as mean relative pixel density (n = 3, mean ± SEM). Asterisk indicates statistical difference (P < 0.05)
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the embryonic genome is mostly activated by the 16-cell
stage and is completely activated in the blastocyst stage
embryo. The methylation status of the 5′ terminal re-
gion near the TSS of developmentally important genes
has been surveyed and all the genes, including Oct4,
Sox2, Nanog, Rex1 and Fgf4, experienced demethylation
after fertilization and the expression of these genes were
not accompanied by the demethylation of their promoter
regions [34]. Therefore, the dynamic methylation
changes in early embryonic development, especially
during MZT, might not contribute to activation of gene
transcription. In this case, the reduction of KPNA7
mRNA level is explained by inactivation of transcrip-
tional activity, however, on the other hand, rapid mRNA
degradation might also be a reason for diminishment of
the KPNA7 transcript.
With 4 predicted miRNA-1296 binding sites in the
coding region of KPNA7 mRNA, the functional role of
miRNA-1296 in regulation of KPNA7 expression was
investigated. Our co-transfection experiments indicated
that miRNA-1296 may play a role in down-regulating
the expression of KPNA7 protein. However, this finding
is limited as we did not show specific binding of
miRNA-1296 to the predicted binding sites on KPNA7
mRNA. Further experiments using reporter constructs
with mutated miRNA-1296 binding sites are needed to
test whether the effect of miRNA-1296 on KPNA
expression is direct or indirect.
The classic miRNA-mediated post-transcriptional
regulation of mRNAs has been believed to be confined
to the 3’UTR region of the transcripts [35]. However,
new studies have demonstrated the existence of many
naturally occurring alternative binding regions of
miRNA in mammalian cells [36, 37]. During embryogen-
esis, miR-134, miR-296 and miR-470 target the coding
regions of transcription factors Nanog, Oct4 and Sox2 in
various combinations, leading to transcriptional and
morphological changes in mouse embryonic stem cells
[36]. In bovine species, Nanog, Oct4 and Sox2 are all
oocyte-specific maternal factors that govern early embry-
onic development by regulating the pluripotency of
blastomeres [38, 39]. Thus, miRNA targeting the coding
regions of developmentally important factors might be a
characteristic feature in post-transcriptional regulation
of maternal effect factors.
Targets of miRNA-1296 have been studied and shown
to be highly involved in essential DNA replication [40].
miRNA-1296 targets MCM2 mRNA in prostate cancer
cells and over expression of miRNA-1296 results in a
significant decrease in MCM2 mRNA, protein, and
S-phase of the cell cycle. MCM2 is an essential DNA
replication factor that is highly expressed in cancer cells
as well as in the oocyte and is highly involved in
resumption of meiosis in mammalian oocytes [41]. The
potential involvement of miRNA-1296 in regulating the
expression of KPNA7 supports a new role of this
miRNA in the control of oocyte and early embryonic
development.
Studies in human cancers have shown that miRNAs
and DNA methylation can mutually regulate each other
Fig. 6 Relative abundance of miR-1296 mRNA in bovine oocytes and in vitro produced bovine early embryos (n = 4 pools of five oocytes/
embryos each). Quantity of miRNA was normalized relative to abundance of miRNA-125b. Different letters indicate statistical difference (P < 0.05)
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[42]. For example, the miRNA-29 family regulates DNA
methylation by targeting DNA methyltransferases
(DNMT3a and DNMT3b) in lung cancer tissues [43],
and the expression of the miRNA-34 family members
(miRNA-34b and miRNA-34c) is silenced by hyperme-
thylation of the promoters of the miRNA genes in gas-
tric cancer cells [44]. It is not clear how the expression
of bovine miRNA-1296 is regulated during embryogen-
esis but DNA methylation of the miRNA gene promoter
could play a role in controlling its expression. There is
currently no evidence showing the involvement of
miRNA-1296 in modulating DNA methyltransferases,
thus affecting DNA methylation.
Conclusions
In this study, we found that the oocyte restricted expres-
sion of bovine KPNA7 is regulated by DNA methylation
at the proximal promoter and demethylation of 3 CpG
sites is closely related to tissue-specific expression of this
gene. We also provided evidence showing that miRNA-
1296 is potentially involved in translational silencing of
bovine KPNA7 through binding sites in the coding
region of KPNA7 mRNA. This study combined two
aspects of epigenetic regulation of gene expression and
discovered distinctive controlling mechanisms for tissue-
and stage-specific expression of bovine KPNA7 gene.
Methods
Sample collection
Bovine tissue samples including heart, lung, muscle,
brain, intestine and spleen were collected at a local abat-
toir. Bovine GV oocytes and early stage embryos were
purchased from Bomed, Inc. (Madison, WI). All samples
were frozen in liquid nitrogen and stored at − 80 °C until
use.
Plasmid construction
The open reading frame (ORF) of bovine KPNA7 cDNA
was PCR amplified from a KPNA7 expression plasmid
[2] and cloned into pcDNA3.1/myc-His vector (Invitro-
gen, Carlsbad, CA) using a forward primer containing a
Kozak sequence and BamHI site and a reverse primer
containing a XhoI site (Additional file 2, Table S1). The
plasmid designed to express the bovine miRNA-1296
was prepared by PCR amplification of a 291 bp genomic
fragment containing the pre-miRNA-1296 followed by
cloning into pcDNA3.1 vector using a forward primer
containing a BamHI site and a reverse primer containing
a PmeI site (Additional file 2, Table S1). Both constructs
were sequenced to ensure that no mutations were intro-
duced during PCR amplification.
Bisulfite sequencing
DNA samples isolated from oocytes/embryos or somatic
tissues were treated by bisulfite following the manufac-
turer’s instructions of the EZ DNA Methylation-Direct™
kit (Zymo Research, Irvine, CA). Primers (Additional file
2, Table S1) were designed using Methprimer online
program and were used in a 25-μl PCR reaction for the
first round of 40 cycles. Cycling conditions were as fol-
lows: 95 °C for 9 min followed by 40 cycles of 95 °C for
30 s, 54 °C for 30 s, 72 °C for 30 s and a final extension of
5 min at 72 °C. Nested PCR of 35 cycles was performed
using the PCR product as a template in a higher anneal-
ing temperature at 58 °C and a shorter denaturation time
of 5 min at 95 °C. The DNA regions of CpG sites were
amplified, and three independent PCR reactions were
performed. The PCR products were purified, pooled to-
gether and cloned into pGEM-T Easy vector (Promega).
After verification, 10 clones for each DNA sample were
sequenced, and the sequences were analyzed using the
online tool QUMA (http://quma.cdb.riken.jp/).
Cell culture
HEK293 cells were cultured in DMEM (Invitrogen,
Carlsbad, CA) containing 10% FBS. For transient trans-
fection, Xtremegene 9 (Roche Applied Science, Indian-
apolis, IN) was used according to manufacturer’s
instructions. Following transfection, cells were incubated
for 24 h before harvest for western blot analysis. CCL22
cells were cultured in DMEM containing 10% HS. 5-
Aza-CdR was added to the culture medium with a final
concentration of 0.5 μM in 6-well plates (Corning Inc.,
Corning, NY) seeded with cells 24 h before the treatment.
Treatment continued for 3 days with fresh 5-Aza-CdR
changed every 24 h. After 3 days, cells were harvested and
stored at − 80 °C until use.
Western blot analysis
Electrophoresis and transfer were performed according
to a previous study with minor modifications [45].
HEK293 cell were harvested with Pierce IP Lysis Buffer
(Thermo Fisher Scientific, Waltham, MA), and 10 μl of
cell lysate were mixed with an equal volume of Laemmli
sample buffer (Bio-Rad Laboratories, Hercules, CA).
Protein samples (15 μg/each) were separated on a 4–20%
gradient ready gel (Bio-Rad) and transferred onto a
Immobilon-FL PVDF membrane (Millipore, Billerica,
MA). Following transfer and blocking in 5% nonfat dry
milk in PBS containing 0.1% Tween-20 (PBST) for one
hour, the membrane was incubated in anti-Myc antibody
(Sigma-Aldrich, St. Louis, MO) diluted 1:1000 and anti-
ACTB antibody (GenScript, Piscataway, NJ) diluted 1:
1000 in blocking buffer overnight at 4 °C. After 3 washes,
two secondary antibodies IRDye 800CW goat anti-rabbit
and IRDye 680LT goat anti-mouse (Li-COR, Lincoln,
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NE) were added to the blocking buffer and incubated for
20 min. Detection of protein was performed following
the instructions of the Odyssey system (Li-COR, Lincoln,
NE). ImageJ software was used to quantify the protein
bands. Abundance of KPNA7 protein was normalized
relative to the abundance of ACTB protein.
Quantitative real-time PCR
cDNA from oocyte and embryo samples (n = 3 pools of
five each) was prepared by lysing the samples in 1× miS-
cript RT buffer containing 0.5% NP-40 at 95 °C for 5
min followed by addition of miScript reverse transcript-
ase mix (Qiagen, Valencia, CA) and incubation at 37 °C
for 60 min. The cDNA was then used for determination
of relative amount of miR-1296 by RT-qPCR using the
miRNA-1296 specific primer and the miScript universal
primer (Qiagen, Valencia, CA). Bovine miRNA-125b was
used as an endogenous control as this miRNA is
expressed consistently in preimplantation embryos [46].
RT-qPCR analysis was performed on the Bio-Rad CFX96
system. The iQ™ SYBR Green Supermix (Bio-Rad,
Hercules, CA) was used in 20 μl reaction volumes con-
taining 100 nM of each primer and 5 μl of diluted cDNA.
Cycling parameters were 95 °C for 15 min, and then 40
cycles of 95 °C for 15 s, 55 °C for 30 s and 70 °C for 30 s.
Standard curves for the target and control miRNA were
constructed using 10-fold serial dilution of a pooled
cDNA sample.
Supplementary information
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1186/s12861-019-0204-x.
Additional file 1: Figure S1. Identification of CpG sites in the proximal
promoter of bovine KPNA7 gene. Analysis of DNA sequence around the
transcription start site (TSS) of bovine KPNA7 gene using Methprimer
(http://www.urogene.org/cgi-bin/methprimer2/MethPrimer.cgi) revealed
multiple CpG sites including a CpG island containing 8 CpG sites (− 221
to − 114) located upstream of the TSS. (PPTX 69 kb)
Additional file 2: Table S1. List of primers used in this study. (XLSX 9
kb)
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